Researchers are excited about the medication , a novel dual treatment showing promising data in initial trials for body loss . It functions by targeting two pathways : GLP-1 and GIP, these, when https://ronalddvqs766331.ssnblog.com/39466482/a-new-prospect-for-weight-loss